Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Partial splenectomy or total splenectomy are the two surgical treatment of non-malignant hemoglobinoptahie. The aim of this treatment is to decrease transfusion. The main risk is infectious in total splenectomy, that's why partial splenectomy was suggest. But the efficiency of partial splenectomy decrease over time and a totalisation could be mandatory.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Children under 18 years olds with total splenectomy for non Malignant hemoglobinopathie | Children under 18 years olds with total splenectomy for non Malignant hemoglobinopathie | ||
| Children under 18 years olds with partial splenectomy for non Malignant hemoglobinopathie | Children under 18 years olds with partial splenectomy for non Malignant hemoglobinopathie |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Compared the effectiveness with the number of transfusion | Compared the effectiveness with the number of transfusion after the surgery between total and partial Febrile urinary tract infection was defined as a positive urine examination with a single bacteria with more than 10.5 cfu/mL and more than 10.4 leukocytes/ml associated with fever above 38.5°C and C-reactive protein (CRP) above 50 mg/ | Day 1 |
| Measure | Description | Time Frame |
|---|---|---|
| Number of infectious event in total and partial splenectomy | Number of infectious event in total and partial splenectomy | Day 1 |
| number of totalisation in partial | number of totalisation in partial |
Not provided
Inclusion criteria:
Exclusion criteria:
- Total or partial splenectomy outside of non malignant hemoglobinopathies
Not provided
Not provided
Not provided
Children under 18 years olds with partial or total splenectomy for non malignant hemoglobinopathies
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Nicolas KALFA, MD | Contact | 00334 67 33 87 84 | n-kalfa@chu-montpellier.fr | |
| Benoit Tessier, Student | Contact | 4 67 33 87 84 | 33 | benoitessier@gmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Nicolas KALFA | University Hospital, Montpellier | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University hospital of Montpellier | Montpellier | 34295 | France |
NC
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Day 1 |